Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.
COVID-19
Cerebellar ataxia
Cerebellum
SARS-CoV-2
Journal
Cerebellum (London, England)
ISSN: 1473-4230
Titre abrégé: Cerebellum
Pays: United States
ID NLM: 101089443
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
15
5
2020
medline:
17
7
2020
entrez:
15
5
2020
Statut:
ppublish
Résumé
The current worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that causes coronavirus disease 2019 (COVID-19) has brought some medical systems to the brink of collapse. This crisis is also negatively impacting the care of patients with non-COVID-19 conditions, including those with cerebellar ataxia (CA). Older patients with CA and those with immune-mediated ataxias on immunosuppressive medication are potentially at high risk of developing serious complications of the infection, although it is also possible that immunosuppressive agents may provide a defense against cytokine storm. This has implications for even greater attention to preventing contracting the disease through physical distancing and/or isolation. The CA patient population is also at higher risk because of the neurological complexities of their underlying disorder and the comorbid medical illnesses that often accompany the genetic ataxias. As the disruption of social patterns and healthcare delivery in response to the crisis continues, interruption of rehabilitation, speech and language therapy, and face-to-face consultations threatens to have a negative impact on the course and well-being of CA patients. Mental and physical health is also potentially at greater risk because the prevailing uncertainty and anxiety may be superimposed upon cerebellum-specific neuropsychological challenges. We identify and review some of the short- and long-term consequences of this global pandemic for the community of ataxia patients and their families and for the clinical and academic neurologists/ataxiologists caring for these patients. This includes the recognition that telemedicine has emerged as a principle means of caregiver-patient contact and that neurological manifestations of COVID-19 including those specific to cerebellar neurobiology are increasingly recognized and will require close surveillance and monitoring. This COVID-19 Cerebellum Task Force consensus provides some guidance on how we may approach this uncertain time and consider preparing for the new realities we face in CA patient care once this acute crisis has passed.
Identifiants
pubmed: 32405955
doi: 10.1007/s12311-020-01139-1
pii: 10.1007/s12311-020-01139-1
pmc: PMC7220536
doi:
Types de publication
Journal Article
Practice Guideline
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
562-568Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Références
J Clin Med. 2020 Mar 30;9(4):
pubmed: 32235486
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Mov Disord. 2010 Oct 15;25(13):2239-46
pubmed: 20737551
Ecancermedicalscience. 2020 Mar 27;14:1022
pubmed: 32256705
Psychiatry Res. 2020 Feb 28;286:112903
pubmed: 32146245
J Neurol Sci. 2020 May 15;412:116803
pubmed: 32247193
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
J Neurol. 2013 Dec;260(12):3134-43
pubmed: 24122064
Brain. 1998 Apr;121 ( Pt 4):561-79
pubmed: 9577385
Cerebellum Ataxias. 2015 Feb 27;2:2
pubmed: 26331045
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Eur J Neurol. 2020 Sep;27(9):1764-1773
pubmed: 32333487
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
J Biol Regul Homeost Agents. 2020 Apr 07;34(2):339-343
pubmed: 32253888